Eastman Chemical Co (EMN) financial statements: income statement, balance sheet and cash flow
Eastman Chemical Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Eastman Chemical Co reported revenue of $8.8B (-6.7% year on year) and net income of $475.0M (-47.7% year on year).
Income statement
Eastman Chemical Co income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Sales
$8.8B
$9.4B
$9.2B
$10.6B
Cost of sales
$6.9B
$7.1B
$7.1B
$8.4B
Gross profit
$1.8B
$2.3B
$2.1B
$2.1B
Selling, general and administrative expenses
$658.0M
$736.0M
$727.0M
$726.0M
Research and development expenses
$255.0M
$250.0M
$239.0M
$264.0M
Asset impairments, restructuring, and other charges, net
$96.0M
$51.0M
$37.0M
$52.0M
Other components of post-employment (benefit) cost, net
($25.0M)
($72.0M)
$41.0M
($101.0M)
Other (income) charges, net
$84.0M
$47.0M
$38.0M
($6.0M)
Gain on divested business
$0
$0
($323.0M)
$43.0M
Earnings before interest and taxes
$776.0M
$1.3B
$1.3B
$1.2B
Net interest expense
$208.0M
$200.0M
$215.0M
$182.0M
Earnings before income taxes
$568.0M
$1.1B
$1.1B
$977.0M
Provision for income taxes
$93.0M
$170.0M
$191.0M
$181.0M
Net earnings
$475.0M
$908.0M
$896.0M
$796.0M
Basic earnings per share attributable to Eastman
$4.14
$7.75
$7.54
$6.42
Diluted earnings per share attributable to Eastman
$4.10
$7.67
$7.49
$6.35
Net earnings including noncontrolling interest
$475.0M
$908.0M
$896.0M
$796.0M
Change in cumulative translation adjustment
$34.0M
($20.0M)
($67.0M)
$7.0M
Prior service credit arising during the period
$157.0M
—
—
$0
Amortization of unrecognized prior service credits included in net periodic costs
($8.0M)
$8.0M
($21.0M)
($27.0M)
Unrealized gain (loss) during period
($44.0M)
$18.0M
($27.0M)
$53.0M
Reclassification adjustment for (gains) losses included in net income, net
$15.0M
$15.0M
$1.0M
($56.0M)
Total other comprehensive income (loss), net of tax
$154.0M
$5.0M
($114.0M)
($23.0M)
Comprehensive income including noncontrolling interest
$629.0M
$913.0M
$782.0M
$773.0M
Less: Net earnings attributable to noncontrolling interest
$1.0M
$3.0M
$2.0M
$3.0M
Comprehensive income attributable to Eastman
$628.0M
$910.0M
$780.0M
$770.0M
Retained earnings at beginning of period
$10.0B
$9.5B
$9.0B
$8.6B
Net earnings attributable to Eastman
$474.0M
$905.0M
$894.0M
$793.0M
Cash dividends declared
($382.0M)
($382.0M)
($377.0M)
($377.0M)
Retained earnings at end of period
$10.1B
$10.0B
$9.5B
$9.0B
Eastman Chemical Co income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Sales
$2.5B
$2.2B
$2.2B
$2.3B
Cost of sales
$2.0B
$1.7B
$1.8B
$1.8B
Gross profit
$560.0M
$431.0M
$433.0M
$506.0M
Selling, general and administrative expenses
$185.0M
$178.0M
$160.0M
$157.0M
Research and development expenses
$65.0M
$60.0M
$63.0M
$67.0M
Asset impairments, restructuring, and other charges, net
$1.0M
$9.0M
$20.0M
$13.0M
Other components of post-employment (benefit) cost, net
($16.0M)
($17.0M)
($1.0M)
($2.0M)
Other (income) charges, net
$14.0M
$13.0M
$3.0M
$49.0M
Earnings before interest and taxes
$311.0M
$188.0M
$188.0M
$222.0M
Net interest expense
$55.0M
$52.0M
$54.0M
$53.0M
Earnings before income taxes
$256.0M
$136.0M
$134.0M
$169.0M
Provision for income taxes
$72.0M
$29.0M
$87.0M
$29.0M
Net earnings
$184.0M
$107.0M
$47.0M
$140.0M
Basic earnings per share attributable to Eastman
$1.60
$0.93
$0.41
$1.22
Diluted earnings per share attributable to Eastman
$1.59
$0.93
$0.40
$1.20
Net earnings including noncontrolling interest
$184.0M
$107.0M
$47.0M
$140.0M
Change in cumulative translation adjustment
($13.0M)
$9.0M
$15.0M
($6.0M)
Amortization of unrecognized prior service credits included in net periodic costs
($8.0M)
($7.0M)
$0
$0
Unrealized gain (loss) during period
$2.0M
$16.0M
$1.0M
($32.0M)
Reclassification adjustment for (gains) losses included in net income, net
$0
$1.0M
$6.0M
$6.0M
Total other comprehensive income (loss), net of tax
($19.0M)
$19.0M
$22.0M
($32.0M)
Comprehensive income including noncontrolling interest
$165.0M
$126.0M
$69.0M
$108.0M
Less: Net earnings attributable to noncontrolling interest
$1.0M
$0
$0
$0
Comprehensive income attributable to Eastman
$164.0M
$126.0M
$69.0M
$108.0M
Net earnings attributable to Eastman
$183.0M
$107.0M
$47.0M
$140.0M
Cash dividends declared
($96.0M)
($98.0M)
($95.0M)
($96.0M)
Retained earnings at end of period
$10.2B
$10.1B
$10.1B
$10.1B
Balance sheet
Eastman Chemical Co balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$566.0M
$837.0M
$548.0M
$493.0M
Trade receivables, net of allowance for credit losses
$737.0M
$791.0M
$826.0M
$957.0M
Miscellaneous receivables
$262.0M
$381.0M
$328.0M
$320.0M
Inventories
$2.0B
$2.0B
$1.7B
$1.9B
Other current assets
$100.0M
$104.0M
$96.0M
$114.0M
Total current assets
$3.6B
$4.1B
$3.5B
$3.8B
Properties and equipment at cost
$14.5B
$14.0B
$13.6B
$12.9B
Less: Accumulated depreciation
$8.8B
$8.4B
$8.0B
$7.8B
Net properties
$5.7B
$5.6B
$5.5B
$5.2B
Goodwill
$3.7B
$3.6B
$3.6B
$3.7B
Intangible assets, net of accumulated amortization
$970.0M
$1.0B
$1.1B
$1.2B
Other noncurrent assets
$848.0M
$833.0M
$820.0M
$855.0M
Total assets
$14.9B
$15.2B
$14.6B
$14.7B
Payables and other current liabilities
$2.1B
$2.3B
$2.0B
$2.1B
Borrowings due within one year
$586.0M
$450.0M
$541.0M
$1.1B
Total current liabilities
$2.7B
$2.7B
$2.6B
$3.3B
Long-term borrowings
$4.2B
$4.6B
$4.3B
$4.0B
Deferred income tax liabilities
$669.0M
$533.0M
$601.0M
$671.0M
Post-employment obligations
$409.0M
$630.0M
$667.0M
$628.0M
Other long-term liabilities
$891.0M
$923.0M
$954.0M
$856.0M
Total liabilities
$8.8B
$9.4B
$9.1B
$9.4B
Common stock, shares issued (in shares)
223.9M
223.6M
222.8M
222.3M
Common Stock, Shares Authorized
350.0M
350.0M
350.0M
350.0M
Common stock, par value (in dollars per share)
$0.01
$0.01
$0.01
$0.01
Common stock ($0.01 par value per share – 350,000,000 shares authorized; shares issued – 223,938,047 and 223,588,347 on December 31, 2025 and 2024, respectively)
$2000000.00
$2000000.00
$2000000.00
$2000000.00
Additional paid-in capital
$2.5B
$2.5B
$2.4B
$2.3B
Retained earnings
$10.1B
$10.0B
$9.5B
$9.0B
Accumulated other comprehensive loss
($160.0M)
($314.0M)
($319.0M)
($205.0M)
Total stockholders' equity before treasury stock
$12.4B
$12.2B
$11.5B
$11.1B
Treasury stock at cost (in shares)
109.9M
108.5M
105.5M
103.6M
Less: Treasury stock at cost (109,891,531 and 108,470,763 shares on December 31, 2025 and 2024, respectively)
6.5B
6.4B
6.1B
5.9B
Total Eastman stockholders' equity
$6.0B
$5.8B
$5.5B
$5.2B
Noncontrolling interest
$76.0M
$73.0M
$72.0M
$83.0M
Total equity
$6.0B
$5.9B
$5.5B
$5.2B
Total liabilities and stockholders' equity
$14.9B
$15.2B
$14.6B
$14.7B
Eastman Chemical Co balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$691.0M
$665.0M
$489.0M
$423.0M
Trade receivables, net of allowance for credit losses
$1.1B
$949.0M
$933.0M
$988.0M
Miscellaneous receivables
$268.0M
$268.0M
$341.0M
$352.0M
Inventories
$2.1B
$2.1B
$1.9B
$2.2B
Other current assets
$98.0M
$96.0M
$87.0M
$107.0M
Total current assets
$4.3B
$4.1B
$3.8B
$4.0B
Properties and equipment at cost
$14.6B
$14.6B
$14.5B
$14.4B
Less: Accumulated depreciation
$9.0B
$8.9B
$8.7B
$8.6B
Net properties
$5.7B
$5.7B
$5.7B
$5.7B
Goodwill
$3.7B
$3.7B
—
$3.7B
Intangible assets, net of accumulated amortization
$924.0M
$946.0M
$1.0B
$1.0B
Other noncurrent assets
$898.0M
$871.0M
$773.0M
$759.0M
Total assets
$15.4B
$15.2B
$15.0B
$15.2B
Payables and other current liabilities
$2.1B
$2.0B
$1.9B
$2.0B
Borrowings due within one year
$765.0M
$770.0M
$290.0M
$344.0M
Total current liabilities
$2.8B
$2.8B
$2.2B
$2.4B
Long-term borrowings
$4.5B
$4.5B
$4.8B
$4.8B
Deferred income tax liabilities
$685.0M
$680.0M
$525.0M
$429.0M
Post-employment obligations
$393.0M
$400.0M
$607.0M
$620.0M
Other long-term liabilities
$879.0M
$838.0M
$1.1B
$1.1B
Total liabilities
$9.2B
$9.1B
$9.1B
$9.3B
Common stock ($0.01 par value – 350,000,000 shares authorized; shares issued – 224,218,154 and 223,938,047 as of June 30, 2026 and December 31, 2025)
2.0M
2.0M
2.0M
2.0M
Additional paid-in capital
$2.5B
$2.5B
$2.5B
$2.5B
Retained earnings
$10.2B
$10.1B
$10.1B
$10.1B
Accumulated other comprehensive income (loss)
($160.0M)
($141.0M)
($331.0M)
($353.0M)
Stockholder's Equity before Treasury Stock
$12.6B
$12.5B
$12.3B
$12.3B
Less: Treasury stock at cost (109,891,531 and 109,891,531 shares as of June 30, 2026 and December 31, 2025)
6.5B
6.5B
6.5B
6.4B
Total Eastman stockholders' equity
$6.1B
$6.0B
$5.8B
$5.8B
Noncontrolling interest
$79.0M
$77.0M
$72.0M
$71.0M
Total equity
$6.2B
$6.1B
$5.8B
$5.9B
Total liabilities and stockholders' equity
$15.4B
$15.2B
$15.0B
$15.2B
Cash flow statement
Eastman Chemical Co cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net earnings
$475.0M
$908.0M
$896.0M
$796.0M
Depreciation and amortization
$513.0M
$509.0M
$498.0M
$477.0M
Mark-to-market pension and other postretirement benefit plans (gain) loss, net
($6.0M)
($54.0M)
$53.0M
$19.0M
Asset impairment charges
$33.0M
$5.0M
$0
$0
Gain on sale of assets
$0
$0
($15.0M)
$15.0M
Gain on divested businesses
$0
$0
$323.0M
($43.0M)
Provision for (benefit from) deferred income taxes
$141.0M
($52.0M)
($102.0M)
($136.0M)
(Increase) decrease in trade receivables
$61.0M
$28.0M
$126.0M
$93.0M
(Increase) decrease in inventories
$24.0M
($344.0M)
$201.0M
($430.0M)
Increase (decrease) in trade payables
($76.0M)
$188.0M
($190.0M)
$60.0M
Pension and other postretirement contributions (in excess of) less than expenses
($60.0M)
($51.0M)
($66.0M)
($149.0M)
Variable compensation payments (in excess of) less than expenses
($22.0M)
$99.0M
$142.0M
($103.0M)
Other items, net
($113.0M)
$51.0M
$154.0M
$290.0M
Net cash provided by operating activities
$970.0M
$1.3B
$1.4B
$975.0M
Additions to properties and equipment
($546.0M)
($599.0M)
($828.0M)
($611.0M)
Government incentives
$21.0M
$9.0M
—
—
Proceeds from sale of businesses
$38.0M
$38.0M
$456.0M
$998.0M
Acquisitions, net of cash acquired
$0
$0
($77.0M)
($1.0M)
Other items, net
$25.0M
$18.0M
$22.0M
$19.0M
Net cash used in investing activities
($462.0M)
($534.0M)
($432.0M)
$392.0M
Net increase (decrease) in commercial paper and other borrowings
$0
$0
($326.0M)
$326.0M
Proceeds from borrowings
$246.0M
$1.2B
$796.0M
$500.0M
Repayment of borrowings
($550.0M)
($1.0B)
($808.0M)
($750.0M)
Dividends paid to stockholders
($381.0M)
($379.0M)
($376.0M)
($381.0M)
Treasury stock purchases
($100.0M)
($300.0M)
($150.0M)
($1.0B)
Other items, net
($12.0M)
$27.0M
($24.0M)
($14.0M)
Net cash used in financing activities
($797.0M)
($454.0M)
($888.0M)
($1.3B)
Effect of exchange rate changes on cash and cash equivalents
$18.0M
($10.0M)
$1.0M
($12.0M)
Net change in cash and cash equivalents
($271.0M)
$289.0M
$55.0M
$34.0M
Cash and cash equivalents at beginning of period
$837.0M
$548.0M
$493.0M
$459.0M
Cash and cash equivalents at end of period
$566.0M
$837.0M
$548.0M
$493.0M
Eastman Chemical Co cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net earnings
$291.0M
$107.0M
$370.0M
$323.0M
Depreciation and amortization
$263.0M
$131.0M
$382.0M
$253.0M
Provision (benefit) from deferred income taxes
$10.0M
($5.0M)
$39.0M
($48.0M)
(Increase) decrease in trade receivables
($369.0M)
($222.0M)
($131.0M)
($183.0M)
(Increase) decrease in inventories
($146.0M)
($119.0M)
$73.0M
($131.0M)
Increase (decrease) in trade payables
$85.0M
$67.0M
($275.0M)
($155.0M)
Pension and other postretirement contributions (in excess of) less than expenses
($48.0M)
($26.0M)
($28.0M)
($17.0M)
Variable compensation payments (in excess of) less than expenses
$22.0M
($49.0M)
($60.0M)
($86.0M)
Other items, net
($21.0M)
($21.0M)
$98.0M
$110.0M
Net cash provided by operating activities
$87.0M
($137.0M)
$468.0M
$66.0M
Additions to properties and equipment
($203.0M)
($103.0M)
($434.0M)
($297.0M)
Sales
$3.0M
$3.0M
$14.0M
$14.0M
Other items, net
($3.0M)
($4.0M)
$5.0M
$5.0M
Net cash used in investing activities
($203.0M)
($104.0M)
($415.0M)
($278.0M)
Net increase in commercial paper and other borrowings
$0
$0
$290.0M
$344.0M
Proceeds from borrowings
$594.0M
$594.0M
$246.0M
$246.0M
Repayment of borrowings
($150.0M)
($150.0M)
($550.0M)
($550.0M)
Dividends paid to stockholders
($192.0M)
($96.0M)
($287.0M)
($191.0M)
Treasury stock purchases
$0
—
($100.0M)
($50.0M)
Other items, net
($11.0M)
($7.0M)
($14.0M)
($13.0M)
Net cash provided by (used in) financing activities
$241.0M
$341.0M
($415.0M)
($214.0M)
Effect of exchange rate changes on cash and cash equivalents